thing antique Swamp ciprofloxacin mic pseudomonas aeruginosa calorie Previous go to work
The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance | npj Biofilms and Microbiomes
Frontiers | Over-Expression of Hypochlorite Inducible Major Facilitator Superfamily (MFS) Pumps Reduces Antimicrobial Drug Susceptibility by Increasing the Production of MexXY Mediated by ArmZ in Pseudomonas aeruginosa
Development of in vitro resistance to fluoroquinolones in Pseudomonas aeruginosa | Antimicrobial Resistance & Infection Control | Full Text
Interspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro - Journal of Pure and Applied Microbiology
MIC breakpoints for Pseudomonas aeruginosa according to EUCAST and CLSI... | Download Table
Concentration–resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model
Antibiotics | Free Full-Text | Synergy between Indoloquinolines and Ciprofloxacin: An Antibiofilm Strategy against Pseudomonas aeruginosa
Minimum bactericidal concentration of ciprofloxacin to Pseudomonas aeruginosa determined rapidly based on pyocyanin secretion - ScienceDirect
In vitro analysis of colistin and ciprofloxacin antagonism of Pseudomonas aeruginosa phage PEV2 infection activities | bioRxiv
MICs of tested antibiotic agents against Pseudomonas aeruginosa | Download Table
MIC and MBC values in µg/mL of ciprofloxacin and amikacin against... | Download Table
Association of multidrug resistance behavior of clinical Pseudomonas aeruginosa to pigment coloration | European Journal of Medical Research | Full Text
History of antibiotic adaptation influences microbial evolutionary dynamics during subsequent treatment | PLOS Biology
Comparative in vitro activity of various antibiotic against planktonic and biofilm and the gene expression profile in Pseudomonas aeruginosa
Frontiers | Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
File:Pseudomonas aeruginosa antibiotic susceptibility testing.jpg - Wikipedia
Suicidal chemotaxis in bacteria | Nature Communications
PDF] Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling | Semantic Scholar
xmlinkhub
MIC over time for quality control strains.a) MIC determ | Open-i
Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis - ScienceDirect
The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa - ScienceDirect
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients - ScienceDirect
Comparative Activity of Ciprofloxacin, Levofloxacin and Moxifloxacin against Klebsiella pneumoniae, Pseudomonas aeruginosa and Stenotrophomonas maltophilia Assessed by Minimum Inhibitory Concentrations and Time-Kill Studies | PLOS ONE
Fluoroquinolone antibiotics: in vitro antibacterial and time-kill bactericidal evaluation against etiology of bacteremia in human immunodeficiency virus (HIV)-infected patients | Bulletin of the National Research Centre | Full Text
Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms | Antimicrobial Agents and Chemotherapy
Table 1 from Structural alterations in Pseudomonas aeruginosa by zingerone contribute to enhanced susceptibility to antibiotics, serum and phagocytes. | Semantic Scholar
MICs of Pseudomonas aeruginosa MDR strains | Download Table
Molecules | Free Full-Text | Activity of Antimicrobial Peptides and Ciprofloxacin against Pseudomonas aeruginosa Biofilms
Molecular Analysis of Pseudomonas aeruginosa Isolates with Mutant gyrA Gene and Development of a New Ciprofloxacin Derivative for Antimicrobial Therapy | Research Communities by Springer Nature